Cargando…
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
BACKGROUND: Tumor necrosis factor (TNF) blockers have a high efficacy in treating Ankylosing Spondylitis (AS), yet up to 40% of AS patients show poor or even no response to this treatment. In this paper, we aim to build an approach to predict the response prior to clinical treatment. METHODS: AS pat...
Autores principales: | Liu, Jing, Zhu, Qi, Han, Jing, Zhang, Hui, Li, Yuan, Ma, Yanyun, He, Dongyi, Gu, Jianxin, Zhou, Xiaodong, Reveille, John D., Jin, Li, Zou, Hejian, Ren, Shifang, Wang, Jiucun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567531/ https://www.ncbi.nlm.nih.gov/pubmed/31195969 http://dx.doi.org/10.1186/s10020-019-0093-2 |
Ejemplares similares
-
Single‐cell analysis reveals innate immunity dynamics in ankylosing spondylitis
por: Liu, Jing, et al.
Publicado: (2021) -
Genetic association of non-MHC region with ankylosing spondylitis in a Chinese population
por: Liu, Jing, et al.
Publicado: (2019) -
Profiling of HLA-B Alleles for Association Studies with Ankylosing Spondylitis in the Chinese Population
por: Yi, Lin, et al.
Publicado: (2013) -
Association between Copy Number Variations HLA-DQA1 and Ankylosing Spondylitis in Chinese Han population
por: Wang, Jiucun, et al.
Publicado: (2013) -
Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma
por: Qin, Wenjun, et al.
Publicado: (2018)